Lack of efficacy (protozoa) - Giardia

Verify with FDA CVM →

VeDDRA Code: 2806

536 adverse event reports referencing this reaction

536
Total Reports
2
Deaths
40.0%
Death Rate

Species Most Affected

Dog 521
Cat 15

Breeds Most Affected

Retriever - Labrador 90
Retriever - Golden 48
Crossbred Canine/dog 23
Shepherd Dog - Australian 20
Shepherd Dog - German 19
Beagle 16
Dog (unknown) 15
Mountain Dog - Bernese 15
Bulldog - French 11
Terrier (unspecified) 11

Associated Drugs

Ivermectin + Pyrantel As Pamoate Salt 174
Milbemycin Oxime + Praziquantel 121
Pyrantel Pamoate;Sarolaner 77
Fenbendazol Granules 37
Milbemycin/Lufenuron/Pzq Chew 27
Moxidectin 22
Fenbendazole 19
Lotilaner 16
Afoxolaner 14
Afoxolaner 75Mg / Moxidectin 360Mcg / Pyrantel 150Mg Chewable Tablet 14
Metronidazole 13
Ivermectin + Pyrantel 12
Eprinomectin + Esafoxolaner + Praziquantel 10
Afoxolaner 150Mg / Moxidectin 720Mcg / Pyrantel 300Mg Chewable Tablet 10
Febantel + Praziquantel + Pyrantel Pamoate 9
Imidacloprid + Moxidectin 9
Afoxolaner 18.75Mg / Moxidectin 90Mcg / Pyrantel 37.5Mg Chewable Tablet 9
Fenbendazol Suspension 8
Milbemycin/Lufenuron Tablets 8
Afoxolaner 37.5Mg / Moxidectin 180Mcg / Pyrantel 75Mg Chewable Tablet 8

Data Summary

Metric Value
Total reports referencing reaction 536
Reports with fatal outcome 2
Case-fatality rate (reported events) 40.0%
Species observed 2
Breeds observed 20
Drugs associated with reaction 20

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER); reaction term coded under VeDDRA 2806.

Lack of efficacy (protozoa) - Giardia Reaction Insights

The FDA Center for Veterinary Medicine database currently lists 536 adverse event reports that reference Lack of efficacy (protozoa) - Giardia as a reaction term, including 2 reports with a death outcome — a 40.0% case-fatality figure calculated across only those events where this reaction was coded. The reaction is indexed in the openFDA system under VeDDRA code 2806, the standardized veterinary dictionary used to normalize clinical signs across submitters. Because reports are voluntary and often describe multiple concurrent signs per animal, the volume here reflects reporting intensity rather than true incidence in the broader pet population.

Lack of efficacy (protozoa) - Giardia appears most frequently in reports for Dog (521 reports), Cat (15 reports) — with Dog dominating at 521 entries. Within those species, the breeds most often named alongside this reaction are Retriever - Labrador (90), Retriever - Golden (48), Crossbred Canine/dog (23). These distributions are influenced both by underlying breed popularity and by how veterinarians and owners code a given clinical sign, so they should be interpreted as a reporting fingerprint rather than a pure susceptibility ranking.

The drugs most commonly co-reported with Lack of efficacy (protozoa) - Giardia are Ivermectin + Pyrantel As Pamoate Salt (174 reports), Milbemycin Oxime + Praziquantel (121 reports), Pyrantel Pamoate;Sarolaner (77 reports), Fenbendazol Granules (37 reports), with Ivermectin + Pyrantel As Pamoate Salt appearing alongside this reaction in 174 submissions. Co-reporting does not establish that any specific product caused the reaction — FDA CVM data captures temporal association only. The value of these aggregates is in flagging which therapeutic classes appear repeatedly alongside a given clinical sign, so owners and veterinarians can ask targeted questions about medications currently in use.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial